Surgical Innovations Group plc announced sales results for the year ended December 31, 2013. for the year, total revenues will be £8.6 million, a 13% increase against the previous year £7.6 million. The group's strategy for long term growth is the development of the SI Brand within the lucrative US market, underpinned by the appointment in May 2013 of an SI President of US Sales and Operations.

The group is therefore pleased to report a substantial increase of 75% in sales to the US of SI Branded products, through multiple new routes to market, clearly demonstrating potential for growth and vindicating the high level of initial investment required. Overall, SI Branded product revenues have grown by 23% driven by the demand for responsible technology.